1. Home
  2. COCP vs APCX Comparison

COCP vs APCX Comparison

Compare COCP & APCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • APCX
  • Stock Information
  • Founded
  • COCP N/A
  • APCX 2006
  • Country
  • COCP United States
  • APCX United States
  • Employees
  • COCP N/A
  • APCX N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • APCX Finance: Consumer Services
  • Sector
  • COCP Health Care
  • APCX Finance
  • Exchange
  • COCP Nasdaq
  • APCX Nasdaq
  • Market Cap
  • COCP 18.2M
  • APCX 15.2M
  • IPO Year
  • COCP N/A
  • APCX N/A
  • Fundamental
  • Price
  • COCP $2.04
  • APCX $0.72
  • Analyst Decision
  • COCP Strong Buy
  • APCX
  • Analyst Count
  • COCP 1
  • APCX 0
  • Target Price
  • COCP $7.00
  • APCX N/A
  • AVG Volume (30 Days)
  • COCP 18.6K
  • APCX 182.6K
  • Earning Date
  • COCP 11-11-2024
  • APCX 11-12-2024
  • Dividend Yield
  • COCP N/A
  • APCX N/A
  • EPS Growth
  • COCP N/A
  • APCX N/A
  • EPS
  • COCP N/A
  • APCX N/A
  • Revenue
  • COCP N/A
  • APCX $462,000.00
  • Revenue This Year
  • COCP N/A
  • APCX $1,315.48
  • Revenue Next Year
  • COCP N/A
  • APCX N/A
  • P/E Ratio
  • COCP N/A
  • APCX N/A
  • Revenue Growth
  • COCP N/A
  • APCX 3.59
  • 52 Week Low
  • COCP $1.33
  • APCX $0.44
  • 52 Week High
  • COCP $3.10
  • APCX $2.85
  • Technical
  • Relative Strength Index (RSI)
  • COCP 61.73
  • APCX 54.49
  • Support Level
  • COCP $1.66
  • APCX $0.66
  • Resistance Level
  • COCP $1.87
  • APCX $0.62
  • Average True Range (ATR)
  • COCP 0.15
  • APCX 0.06
  • MACD
  • COCP 0.04
  • APCX 0.03
  • Stochastic Oscillator
  • COCP 48.10
  • APCX 90.03

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About APCX AppTech Payments Corp.

AppTech Payments Corp is a FinTech company utilizing various payment processing and digital banking technologies to complement core merchant services capabilities. The company's patented and proprietary software will provide progressive and adaptable products that are available through a suite of synergistic offerings directly to merchants, banking institutions, and business enterprises. It is developing a secure digital payments and banking platform that powers commerce experiences for clients and customers. Based upon industry standards for payment and banking protocols, the company will offer standalone products and fully integrated solutions that deliver unparalleled payments, banking, and financial services experiences.

Share on Social Networks: